application - International Pharmaceutical Industry

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Volume 15 Issue 3

At last! The Advent of Better Software Application UX to Manage Critical Manufacturing Processes in Highly Regulated Industries

For too long, professionals in the manufacturing industry have had to cope with software applications that are designed more for function than usability despite the ...

29 September 2023 Volume 15 Issue 3 Advent | application

Continue Reading →

Volume 14 Issue 4

EU CTR: Final Countdown, What You Need to Know

The end of the transition period is imminent. How can clinical trial sponsors and CROs ease the transition to CTIS? Soon, the one-year transition period of the EU...

13 January 2023 Volume 14 Issue 4 application | approval

Continue Reading →

News

AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax

AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive...

17 July 2018 News AbbVie | announces

Continue Reading →

News

Brussels Airport launches blockchain application on their winning BRUcloud data sharing platform

Last month, during the Air China Cargo exhibition in Shanghai, Brussels Airport and their cargo community won the award for “IT solution of the year” with BRUclo...

14 June 2018 News airport | application

Continue Reading →

News

Invivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 Mutations

Invivoscribe Technologies, Inc. announced today that they have submitted to Japan's Pharmaceutical and Medical Devices Agency (PMDA) and the US Food and Drug Adminis...

8 May 2018 News application | approval

Continue Reading →

News

Starpharma completes US New Drug Application for VivaGel BV

VivaGel BV stands to be the first and only product approved for the prevention of recurrent BV Australian pharma giant Starpharma today announced that its rollin...

1 May 2018 News application | BV

Continue Reading →

News

Wickham Laboratories Holdings Announces Planning Application Approval

Outline planning permission application for expansion of the Hoeford Point site now approved. Wickham Laboratories Holdings, owner of Wickham Laboratories Ltd...

23 January 2018 News application | approval

Continue Reading →

News

Elpis BioMed closes funding round to commercialise novel technology platform for generating human cell types

Elpis BioMed Ltd (Elpis), a University of Cambridge spin-out, applying its disruptive and proprietary “direct cell reprogramming” platform to produce pure, mature an...

20 November 2017 News application | cell

Continue Reading →